CBD vs. THC
July 27, 2023

CBD vs. THC

Written by: Timothy Culbert, MD, IFMCP

Here's the main difference between CBD and THC. THC will get you high, CBD won't (or shouldn't if it's high quality). Put in a more science-y way, CBD is a non-intoxicating cannabinoid that has effects on the body and brain but does not cause the sensory and psychological effects that THC does. 

Psychoactive vs. Intoxicating

A common term used with CBD and THC is "psychoactive." It's helpful to understand the difference between these terms.

  • A psychoactive compound is a chemical substance that acts primarily on the central nervous system and alters brain function, resulting in temporary changes in perception, mood, consciousness, or behavior. 
  • An intoxicating substance refers to a chemical substance that stimulates, excites, or impairs judgment. Most often, if someone is intoxicated, they aren't able to act in the cautious and appropriate ways that they would when not intoxicated.

THC is an intoxicating cannabinoid that creates a “high” feeling or the sensation described as being “stoned."

CBD is a non-intoxicating cannabinoid that has effects on the body and brain but does not cause the sensory and psychological effects that THC does. 

So, are THC and CBD psychoactive? Yes! But, in many different ways. CBD's application for seizure conditions is a good example of why CBD should be labeled psychoactive. CBD's ability to interact with the brain and central nervous system in this way is a good reminder of the potential power of CBED. It's also a reminder of how essential it is to use a high quality CBD and to use it only as needed. Like with most things, more is rarely better. Research is still in its infancy and excessive, or even high doses on a daily basis, have yet to be tested appropriately. 

 

CBD Supplements at Natural Mental Health

  • Sleep CBD is a blend of broad-spectrum CBD (30 mg per serving) combined with 5 mg of CBN (cannabinol) and 3 mg of melatonin. CBN is a form of phytocannabinoid shown to be more specifically helpful for sleep, and melatonin is nature’s internal timekeeper, helping set a more consistent bedtime. CBD Sleep may improve a variety of challenging sleep issues, and is especially helpful for those who have trouble falling asleep. 

  • Calm CBD combines 30 mg of broad-spectrum CBD with 200 mg of l-theanine, an amino acid that can also help reduce anxiety and stabilize mood. Together, they may improve stress resilience and calm anxiety without sedation. Taken at bedtime, CBD Calm may also be helpful for those who tend to wake in the middle of the night.

 

  • Restore CBD gummies are infused with the highest quality, all-natural, US-grown hemp. Each gummy offers a precise dose of broad-spectrum CBD to support your endocannabinoid system with naturally occurring, plant-based ingredients. This synergy of multiple cannabinoids work together for the greatest impact to restore your natural resilience. 

 

 

SOURCES
  1. Abrams, D. (2018). The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. European journal of internal medicine, 49, 7-11.
  2. Atakan, Z. (2012). Cannabis, a complex plant: different compounds and different effects on individuals. Therapeutic advances in psychopharmacology, 2(6), 241-54. doi:10.1177/2045125312457586
  3. Ballard, C. R., & Junior, M. R. M. (2019). Health benefits of flavonoids. In Bioactive compounds (pp. 185-201). Woodhead Publishing.
  4. Bridgeman, M. B., & Daniel T. A. (2017). Medicinal cannabis: History, pharmacology, And implications for the acute care setting. P&T: A peer-reviewed journal for formulary management, 42(3), 180-188.
  5. Cox-Georgian, D., Ramadoss, N., Dona, C., & Basu, C. (2019). Therapeutic and medicinal uses of terpenes. In Medicinal Plants (pp. 333-359). Springer, Cham.
  6. Morales, P. et al. (2017). Molecular targets of the phytocannabinoids: A complex picture. Progress in the chemistry of organic natural products, 103, 103-131. doi:10.1007/978-3-319-45541-9_4
  7. Noreen N., Muhammad, F., Akhtar, B., Azam, F., & Anwar, M. I. (2018). Is cannabidiol a promising substance for new drug development? A review of its potential therapeutic applications. Crit Rev Eukaryot Gene Expr, 28(1), 73-86. doi: 10.1615/CritRevEukaryotGeneExpr.2018021528. 
  8. Sarris, J. et al. (2020). Medicinal cannabis for psychiatric disorders: A clinically-focused systematic review. BMC Psychiatry, 20(1). doi:10.1186/s12888-019-2409-8
  9. Wong, S. S., & Wilens, T. E. (2017). Medical cannabinoids in children and adolescents: a systematic review. Pediatrics, 140(5).